ARTICLE | Distillery Therapeutics
Inhibiting NOX2 or FOXC1 to treat AML and CML
April 15, 2019 7:25 PM UTC
INDICATION: Acute myelogenous leukemia (AML); chronic myelogenous leukemia (CML)...
BCIQ Company Profiles
INDICATION: Acute myelogenous leukemia (AML); chronic myelogenous leukemia (CML)...
BCIQ Company Profiles
BCIQ Company Profiles